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The association between dietary fat and fertility is not well studied. We evaluated intakes of total fat, saturated fatty
acids, monounsaturated fatty acids, polyunsaturated fatty acids, trans fatty acids (TFA), ω-3 fatty acids, and ω-6 fatty
acids in relation to fecundability in Danish and North American preconception cohort studies. Women who were at-
tempting to become pregnant completed a validated food frequency questionnaire at baseline. Pregnancy status was
updated bimonthly for 12months or until pregnancy. Fecundability ratios (FR) and 95% conﬁdence intervals were esti-
mated using multivariable proportional probabilities regression. Intakes of total fat and saturated, monounsaturated,
polyunsaturated, and ω-6 fatty acids were not appreciably associated with fecundability. TFA intake was associated
with reduced fecundability in North American women (for the fourth quartile vs. the ﬁrst, FR = 0.86, 95% conﬁdence
interval (CI): 0.71, 1.04) but not Danish women (for the fourth quartile vs. the ﬁrst, FR = 1.04, 95% CI: 0.86, 1.25),
though intake among Danish women was low. In North America, ω-3 fatty acid intake was associated with higher fe-
cundability, but there was no dose-response relationship (among persons who did not use ﬁsh oil supplements: for the
fourth quartile vs. the ﬁrst, FR = 1.40, 95% CI: 1.13, 1.73); no association was found in Danish women, among whom
low intake was rare. In the present study, high TFA intake and low ω-3 fatty acid intake were associated with reduced
fecundity.
fatty acids; fertility; internet; prospective studies; trans fatty acids
Abbreviations: BMI, bodymass index; CI, conﬁdence interval; FFQ, food frequency questionnaire; FR, fecundability ratio; LMP, last
menstrual period; MET, metabolic equivalent; MUFA, monounsaturated fatty acid; PRESTO, Pregnancy Study Online; PUFA,
polyunsaturated fatty acid; SD, standard deviation; SF, Snart Foraeldre; SFA, saturated fatty acid; TFA, trans fatty acid; TTP,
time to pregnancy.
Approximately 10%–15% of couples experience infertility,
which is clinically deﬁned as inability to conceive after 12
months of unprotected intercourse (1). Fats comprise 30%–
40% of daily energy intake in Western countries. They are
essential components of cell membranes and can modulate the
expression of enzymes involved in the metabolism of prosta-
glandins and steroid hormones, which are critical for reproduc-
tion (2). The association between dietary fat intake and fertility
has not been studied extensively. Fat-rich diets have been asso-
ciated with poor oocyte development, possibly related to the
induction of oxidative stress in the follicular environment (3,
4). However, the type of fat likely matters. In a prospective
cohort study of female nurses, a higher intake of trans fatty
acids (TFAs) was associated with ovulatory infertility (5) and
endometriosis (6). In animal studies, a higher intake of ω-3
fatty acids has been associated with improvedmarkers of fertil-
ity (7–9), particularly inmale rodents (8, 9), but evidence in hu-
mans is limited (10–14).
We assessed the association between dietary fat consump-
tion and time to pregnancy (TTP) among women participating
in preconception cohort studies in Denmark and North Ameri-
ca. Speciﬁcally, we examined total dietary fat intake and in-
takes of major subtypes of fatty acids, including saturated fatty
acid (SFA), polyunsaturated fatty acid (PUFA), monounsatu-
rated fatty acid (MUFA), TFA, ω-3 fatty acids, and ω-6 fatty
acids in relation to fecundability.
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METHODS
Study population
Snart Foraeldre (“Soon Parents”) (SF) is a prospective cohort
study of women who were attempting to become pregnant in
Denmark. SF is an expansion of the Snart Gravid (“Soon Preg-
nant”) study, which has been described previously (15, 16).
Recruitment for SF was Internet-based and began in 2011 with
advertisements placed on Danish health-related websites and
blogs. Enrollment and primary data collection were conducted
via online self-administered questionnaires. Beginning in Janu-
ary 2013 (10 days after enrollment), participants were invited to
complete a comprehensive food frequency questionnaire (FFQ)
designed speciﬁcally for this population (17). Eligible women
were 18–45 years of age, residents of Denmark, in a stable rela-
tionship with a male partner, planning a pregnancy, and not
receiving fertility treatment.
From 3,128 eligible SF participants, we excluded 533 who
did not complete at least 1 follow-up questionnaire, 52 whose
last menstrual period (LMP) was more than 6 months before
study entry, and 77 who had missing or implausible LMP infor-
mation or who were pregnant at study entry. Furthermore, in an
effort to avoid misclassiﬁcation of diet due to subfertility, we
limited our analyses to the 2,053 womenwho had been trying to
conceive for 6 cycles or fewer at study entry. Among these,
1,166 women completed the FFQ once it was implemented
(83% completion). We then excluded 24 women with implausi-
ble total energy intakes (<600 or >3,800 kcal/day) and 16 who
hadmore than 12missing food items on the FFQ, for a ﬁnal ana-
lytic sample of 1,126 women. SF was approved by the Danish
Data Protection Agency and the Institutional Review Board at
Boston UniversityMedical Center.
Pregnancy Study Online (PRESTO) is also an Internet-based
preconception cohort study of North American women who
were attempting to become pregnant; it was modeled after SF
(18). Recruitment began in 2013. Eligible women were 21–45
years of age, residents of theUnited States or Canada, in a stable
relationship with a male partner, planning a pregnancy, and not
receiving fertility treatments. Ten days after completion of the
baseline questionnaire, PRESTO participants were invited to
complete the National Cancer Institute’s Dietary Health Ques-
tionnaire II (19), a Web-based FFQ. Of the 2,576 eligible parti-
cipants who completed the baseline questionnaire, we excluded
487 women with no follow-up data, 30 whose baseline LMP
was more than 6 months before study entry, and 41 with miss-
ing or implausible LMP data or who were pregnant at study
entry. Of the 2,018 remainingwomen, we excluded 280women
who had been trying to conceive for more than 6 cycles at study
entry. Among these, 1,310 completed the FFQ (75% comple-
tion). We additionally excluded 20 women with implausible
total energy intakes (<600 or >3,800 kcal/day), for a ﬁnal ana-
lytic sample of 1,290 women. PRESTO was approved by the
Institutional Review Board at Boston University Medical Cen-
ter. Participants in both studies provided online informed con-
sent. Web Figure 1 (available at https://academic.oup.com/aje)
is a ﬂow chart of analytic exclusions for each cohort.
Baseline questionnaires for SF and PRESTO included infor-
mation on demographic, lifestyle, and behavioral factors, as well
as reproductive and medical histories. To determine pregnancy
status, self-administered online follow-up questionnaires were
completed every 8 weeks for 12 months or until a reported
conception.
Assessment of fatty acid intake
Dietary fat intake was estimated using the nutrient composi-
tion of all food items in the FFQ and validated in each population
(17, 19). Total dietary fat intake was calculated by summing all
servings of fat from individual foods and mixed recipes. In SF,
information about the fat content of speciﬁc foods was obtained
from the Danish nutrient database (20). In PRESTO, we used
the National Cancer Institute’s DIET*CALC software (version
1.5.0) (21) to estimate fat consumption.
In the SF dietary validation study, deattenuated correlation
coefﬁcients when comparing the FFQ data to 4-day food records
were 0.63 for total fat, 0.61 for SFA, 0.59 for MUFA, and 0.49
for PUFA (17). In the Dietary Health Questionnaire II validation
study, deattenuated correlation coefﬁcients when comparing the
FFQ data to repeated 24-hour dietary recalls were 0.66 for total
fat, 0.66 for SFA, 0.62 forMUFA, and 0.64 for PUFA (19).
Assessment of TTP
We estimated TTP using data from the baseline and follow-
up questionnaires.Women with regular menstrual cycles were
asked to report their usualmenstrual cycle length.Amongwomen
with irregular cycles, we estimated menstrual cycle length based
on date of LMP at baseline and prospectively reported LMPdates
during follow-up. We estimated TTP, in discrete menstrual cy-
cles, using the following formula: [(reported cycles of pregnancy
attempt time at baseline) + [(LMP date from most recent follow-
up questionnaire − date of baseline questionnaire)/cycle
length] + 1]. TTP was rounded to the nearest whole number.
Assessment of covariates
Information on potential confounders (including age, race/
ethnicity (PRESTO only), educational level, household income,
height, weight, physical activity level, smoking, alcohol con-
sumption, marital status, last method of contraception, parity,
and use of supplements (including ﬁsh oil supplements)) was re-
ported on the baseline questionnaire. We calculated body mass
index (BMI) as weight in kilograms divided by height in meters
squared. In SF, total metabolic equivalent (MET)–hours per
week were calculated using the International Physical Activ-
ity Questionnaire short-form by summing the MET-hours
fromwalking, moderate physical activity, and vigorous phys-
ical activity (hours/week × 3.3 METs, 4 METs, and 8 METs,
respectively) (22). In PRESTO, total MET-hours per week were
calculated bymultiplying the average number of hours per week
spent engaging in various activities by METs estimated from
the Compendium of Physical Activities (23, 24). Potential
confounders examined in the 2 cohorts were identical except
for race/ethnicity (ascertained in PRESTO only) and educa-
tional level, which was ascertained differently across the 2
studies.
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Data analysis
We performed parallel analyses across the 2 cohorts. Dietary
fat intakes were categorized into quartiles based on the data distri-
bution of the percentage of energy from each type of dietary fat
(25). We analyzed data on total dietary fat and subtypes of fat
(SFA, PUFA, MUFA, and TFA), as well as ω-3 and ω-6 fatty
acids. We also assessed the ratio of ω-6 to ω-3 fatty acids because
the average intake ofω-6 has increasedmarkedly inWestern diets,
whereas the average intake of ω-3 fatty acids has decreased over
time (2, 26). ω-3 fatty acids may have anti-inﬂammatory effects,
whereas ω-6 fatty acids (linoleic and arachidonic acid) tend to be
proinﬂammatory (27). In addition to categorical analyses, we used
restricted cubic splines to model the association between fat and
fecundabilitywithout imposing linearity on the association (28).
Women contributed at-risk menstrual cycles to the analysis
until they reported pregnancy or one of the following censoring
events: initiation of fertility treatment, cessation of pregnancy at-
tempts, withdrawal, loss to follow-up, or 12 cycles, whichever
came ﬁrst. To account for variation in pregnancy attempt time at
study entry (range, 0–6 cycles) and to reduce bias from left trun-
cation (29, 30), we based risk sets only on observed cycles at risk
using theAnderson-Gill data structure (31).We used proportional
probabilities regression models (32, 33) to estimate fecundability
ratios (FR), deﬁned as the ratio of the cycle-speciﬁc probability of
conception comparing exposed women with unexposed women.
This model controls for the decline in fecundability over time by
adjusting for binary indicators of cycle number at risk.
Potential confounders were selected based on the literature
and assessment of a causal graph (Web Figure 2). We included
potential risk factors for subfertility that were associated with
total fat intake. Final models were adjusted for age (<25, 25–29,
30–34, or≥35 years), BMI (<20, 20–24, 25–29, or≥30), smok-
ing status (never, former, current occasional, or current regular
smoker), parity (0 vs. ≥1 births), alcohol consumption (<1, 1–6,
7–13, or ≥14 drinks/week), physical activity level (<10, 10–19,
20–39, or ≥40 MET-hours/week), last contraceptive method
(hormonal, barrier, or natural methods), intercourse frequency
(<1, 1, 2–3, or≥4 times per week), andmarital status (married or
living as married vs. not). PRESTO models were adjusted addi-
tionally for race/ethnicity (non-Hispanic white: yes vs. no), edu-
cational level (high school diploma or less, some college,
college degree, or graduate school), and household income
(<50,000, 50,000–99,999, 100,000–149,999, or ≥150,000
USD). SFmodels were adjusted additionally for vocational train-
ing (none, basic/semiskilled, and <3, 3–4, or ≥5 years of higher
education) and household income (<12,500, 12,500–24,999,
25,000–39,999, 40,000–64,999, 65,000–80,000,r>80,000 Dan-
ish krones). Models for dietary fat were adjusted for total energy
intake by including a continuous energy intake variable in the
regression models (34). We additionally constructed models
adjusted for total fat (to interpret the relative proportion of each
fatty acid group) and for the remaining fatty acids (to interpret in-
creases in each type of fatty acid, holding the rest constant). In
the assessment of ω-3 fatty acids, additional analyses were
restricted to persons who did not use ﬁsh oil supplements.
In secondary analyses, we stratiﬁed the models by preg-
nancy attempt time at study entry (<3 vs. 3–6 cycles) to assess
the extent to which reverse causation could have explained
our results (e.g., whether subfertility caused a change in fat
intake). We also reasoned that ﬁndings might differ by age and
obesity status, given their strong relationship to fecundability and
evidence that they might modify fat-fertility associations (5, 14).
Therefore, we stratiﬁed models by age (<30 vs. ≥30 years) and
BMI (<25 vs. ≥25). Out of concern that parity could be a causal
intermediate (35, 36), models were ﬁt with and without adjust-
ment for parity. Results frommodels in whichwe excluded inter-
course frequency, a potential causal intermediate, were similar to
those from the original models.
We usedmultiple imputation to impute missing covariate data
(37). Covariate missingness in SF ranged from 0% (age and fat
intake) to 6% (household income). In PRESTO, covariate miss-
ingness ranged from 0% (age, educational level, parity, marital
status, and fat intake) to 3.3% (household income). Within each
cohort, we used PROCMI to create 5 imputed data sets based on
imputation models with at least 100 covariates. We combined
coefﬁcients and standard errors across the imputed data sets using
PROC MIANALYZE. Analyses were conducted using SAS,
version 9.4 (SAS Institute, Inc., Cary, North Carolina) (38).
RESULTS
During 2013–2016, a total of 1,290 PRESTO participants con-
tributed 818 pregnancies and 5,579menstrual cycles of pregnancy
attempt time, and 1,126 SF participants contributed 774 pregnan-
cies and 4,307 menstrual cycles of pregnancy attempt time. The
distributions of total dietary fat intakewere similar in the 2 cohorts
except for TFA, the intake of which was markedly lower in SF,
and forω-3 fatty acids and saturated fat, the intakes of whichwere
higher in SF. In PRESTO, mean percentages of energy intake
were 37.58% (standard deviation (SD), 6.88) for total fat, 7.83%
(SD, 2.11) for PUFA, 11.47% (SD, 2.37) for SFA, 14.90% (SD,
3.54) for MUFA, 6.89% (SD, 1.84) for ω-6 fatty acids, 0.87%
(SD, 0.45) for ω-3 fatty acids, and 1.62% (SD, 0.49) for TFA. In
SF, mean percentages of energy intake were 36.20% (SD, 5.50)
from total fat, 5.66% (SD, 0.87) for PUFA, 14.25% (SD, 2.74)
for SFA, 13.50% (SD, 2.51) for MUFA, 4.39% (SD, 0.69) for
ω-6 fatty acids, 1.07% (SD,.26) for ω-3 fatty acids, and 0.60%
(SD, 0.19) for TFA. The top 5 foods that contributed to each fat
subtype are shown inWebTable 1.
Table 1 presents baseline characteristics of study participants
according to quartiles of total dietary fat, TFA, and ω-3 fatty
acid intakes. Intake of total dietary fat was positively associated
with nulliparity and smoking in both cohorts. Although total die-
tary fat intake was associated with lower BMI and physical
activity level in PRESTO, it was associated with higher BMI
and physical activity level in SF. TFA intake was inversely asso-
ciated with nulliparity, physical activity level, and income in
both cohorts and with educational level and alcohol intake in
PRESTO only. In PRESTO, intake of ω-3 fatty acids was posi-
tively associated with educational level and alcohol intake and
inversely associatedwith BMI. Although intake ofω-3 fatty acids
was associated with higher household income in PRESTO, it was
associated with lower household income in SF. In PRESTO,
TFA and ω-3 fatty acid intakes were lower among non-Hispanic
whites than among other racial/ethnic groups.
Intakes of total dietary fat as well as SFAs, MUFAs, and
PUFAs were not appreciably associated with fecundability in
either cohort after adjustment for several potential confounders
(Table 2). After further adjustment for total dietary fat in
Am J Epidemiol. 2018;187(1):60–74
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Table 1. Baseline Characteristics of Study Participants, Pregnancy Study Online (n= 1,290), United States and Canada, and Snart Foraeldre (n= 1,126), Denmark, 2013–2016
Characteristic
% Energy FromTotal Dietary Fat % Energy From Trans Fatty Acids %Energy Fromω-3 Fatty Acids
PRESTO Snart Foraeldre PRESTO Snart Foraeldre PRESTO Snart Foraeldre
Q1 (n = 319) Q4 (n = 323) Q1 (n = 277) Q4 (n = 278) Q1 (n = 358) Q4 (n = 283) Q1 (n = 270) Q4 (n = 277) Q1 (n = 309) Q4 (n = 344) Q1 (n = 271) Q4 (n = 282)
Age, yearsa 29.8 (4.0) 30.6 (3.8) 28.3 (4.3) 28.0 (4.3) 30.7 (4.0) 29.4 (4.1) 28.2 (4.1) 28.1 (4.4) 29.7 (4.0) 30.7 (4.0) 28.5 (4.5) 28.8 (4.4)
Total energy, kcala 1,533 (519) 1,698 (514) 1,905 (529) 1,841 (573) 1,550 (481) 1,620 (550) 1,800 (479) 1,941 (588) 1,568 (492) 1,675 (543) 1,835 (517) 1,810 (548)
BMIa,b 26.6 (6.8) 25.7 (6.2) 23.7 (4.7) 24.4 (5.2) 24.7 (5.3) 28.4 (7.4) 23.9 (4.7) 24.5 (5.9) 26.5 (6.8) 25.2 (6.0) 24.1 (5.1) 24.2 (4.9)
Education, yearsc
≤12 2.5 1.2 15.2 12.6 0.8 3.2 15.9 15.5 1.6 1.7 18.1 11.0
≥17 44.8 49.9 38.6 39.6 55.0 39.9 38.9 34.7 44.0 54.1 42.4 37.6
Never smoker 78.4 75.9 76.2 70.9 79.9 78.5 79.3 67.2 80.9 77.9 70.9 71.3
Alcohol intake of ≥7 drinks/week 16.0 14.2 7.2 10.8 20.1 9.9 6.7 10.8 13.9 17.4 7.4 9.2
User of ﬁsh oil supplements 13.5 28.5 14.6 24.5 26.3 12.0 18.7 16.3 14.6 28.2 15.3 21.0
Nulliparous 72.1 76.8 62.5 69.4 78.2 66.8 67.4 62.5 69.3 72.7 63.8 69.2
Intercourse frequency, times/week
<1 18.2 23.2 15.9 15.5 20.7 19.4 16.7 19.1 20.1 17.7 22.1 11.4
≥4 13.8 11.2 13.4 19.4 15.4 14.1 16.7 16.3 16.2 13.4 16.6 20.6
Physical activity, MET-hours/week
<10 8.8 7.4 11.9 9.7 4.5 14.5 9.6 13.4 9.1 7.9 14.8 6.0
≥40 46.1 42.7 43.0 51.8 57.5 31.8 51.5 45.5 44.3 44.2 41.7 55.3
Last method of contraception: OCs 43.6 31.6 56.0 56.1 36.9 39.6 58.5 57.0 42.1 33.1 58.7 49.3
Household income (PRESTO/SF)d
<$50,000/<24,999 kr 14.1 13.6 15.2 17.3 8.4 23.3 16.7 20.9 17.2 13.7 15.9 15.3
≥$150,000/≥65,000 kr 17.9 22.6 23.5 20.9 26.3 13.1 24.1 17.3 14.9 24.1 26.9 20.2
Married or living as married 96.9 96.6 96.8 94.6 97.2 96.5 96.7 94.6 97.1 96.2 94.8 96.5
Non-Hispanic whitee 90.0 86.7 91.1 85.5 91.9 83.4
Abbreviations: BMI, body mass index; DDK, Danish Kroners; MET, metabolic equivalents; OCs, oral contraceptives; PRESTO, Pregnancy Study Online; Q, quartile; SF, Snart Foraeldre.
a Values are expressed asmean (standard deviation).
b Weight (kg)/height (m)2.
c Education in PRESTO and vocational training in SF.
d Household income for PRESTO is in US dollars and Snart Foraeldre is in Danish kroner.
e Information on race/ethnicity is not available for Snart Foraeldre.
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Table 2. Intake of Total Dietary Fat andMajor Fat Subtypes in Relation to Fecundability, Pregnancy Study Online (n= 1,290), United States and Canada, and Snart Foraeldre (n= 1,126),
Denmark, 2013–2016
Study andQuartile % EnergyMedian (Range)
No. of
Women
No. of
Pregnancies
No. of
Cycles at Risk FR
a 95%CI FRb 95%CI FRc 95%CI FRd 95%CI
Total Fat
PRESTO
1 30.2 (15.5–32.9) 319 192 1,395 1.00 Referent 1.00 Referent
2 34.9 (32.9–37.0) 311 206 1,390 1.11 0.93, 1.33 1.10 0.92, 1.32
3 39.4 (37.0–42.0) 337 216 1,402 1.12 0.94, 1.34 1.12 0.93, 1.34
4 45.4 (42.1–67.2) 323 204 1,392 1.05 0.88, 1.26 1.08 0.90, 1.30
Snart Foraeldre
1 30.4 (15.1–32.7) 277 196 1,078 1.00 Referent 1.00 Referent
2 34.4 (32.7–35.7) 268 183 1,071 0.92 0.77, 1.11 0.90 0.75, 1.08
3 37.5 (35.7–39.4) 303 214 1,081 1.10 0.92, 1.30 1.08 0.91, 1.28
4 41.8 (39.4–66.4) 278 181 1,077 0.94 0.78, 1.12 0.90 0.75, 1.08
Saturated Fat
PRESTO
1 8.9 (4.3–10.0) 332 205 1,390 1.00 Referent 1.00 Referent 1.00 Referent
2 10.8 (10.0–11.5) 333 224 1,396 1.07 0.90, 1.27 1.08 0.91, 1.28 1.02 0.85, 1.22
3 12.2 (11.5–13.0) 323 211 1,396 1.03 0.87, 1.23 1.10 0.92, 1.31 1.01 0.83, 1.22
4 14.2 (13.1–22.0) 302 178 1,397 0.87 0.72, 1.05 0.91 0.75, 1.10 0.78 0.62, 0.99
Snart Foraeldre
1 11.4 (6.1–12.4) 277 191 1,074 1.00 Referent 1.00 Referent 1.00 Referent
2 13.2 (12.4–14.1) 290 204 1,078 1.02 0.85, 1.21 0.94 0.79, 1.12 0.94 0.77, 1.15
3 14.8 (14.1–15.7) 274 184 1,078 0.99 0.82, 1.18 0.96 0.80, 1.15 0.96 0.77, 1.20
4 17.0 (15.7–31.2) 285 195 1,077 1.01 0.85, 1.21 0.96 0.80, 1.15 0.96 0.73, 1.27
Monounsaturated Fat
PRESTO
1 11.2 (4.5–12.4) 317 198 1,390 1.00 Referent 1.00 Referent 1.00 Referent
2 13.4 (12.4–14.4) 310 193 1,396 0.98 0.82, 1.18 0.95 0.79, 1.14 0.91 0.75, 1.11
3 15.7 (14.4–17.0) 334 215 1,400 1.05 0.88, 1.26 1.02 0.85, 1.22 0.94 0.75, 1.19
4 19.0 (17.0–32.4) 329 212 1,393 1.04 0.87, 1.25 1.05 0.87, 1.26 0.93 0.68, 1.26
Snart Foraeldre
1 11.0 (5.1–11.9) 283 203 1,079 1.00 Referent 1.00 Referent 1.00 Referent
2 12.6 (11.9–13.2) 271 182 1,075 0.89 0.75, 1.07 0.86 0.71, 1.02 0.83 0.68, 1.02
3 13.9 (13.2–14.8) 286 204 1,075 1.05 0.88, 1.24 1.01 0.85, 1.20 0.96 0.76, 1.22
4 16.1 (14.8–26.0) 286 185 1,078 0.92 0.77, 1.10 0.89 0.74, 1.07 0.82 0.60, 1.13
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Table 2. Continued
Study andQuartile % EnergyMedian (Range)
No. of
Women
No. of
Pregnancies
No. of
Cycles at Risk FR
a 95%CI FRb 95%CI FRc 95%CI FRd 95%CI
Polyunsaturated Fat
PRESTO
1 5.7 (2.8–6.3) 323 197 1,394 1.00 Referent 1.00 Referent 1.00 Referent
2 6.9 (6.3–7.4) 303 197 1,394 1.01 0.84, 1.21 0.95 0.79, 1.15 0.94 0.78, 1.13
3 8.1 (7.4–8.9) 318 209 1,400 1.06 0.89, 1.27 1.01 0.84, 1.21 0.98 0.80, 1.20
4 10.1 (8.9–18.2) 346 215 1,391 1.08 0.91, 1.30 1.07 0.89, 1.28 1.01 0.80, 1.28
Snart Foraeldre
1 4.8 (2.5–5.1) 277 189 1,070 1.00 Referent 1.00 Referent 1.00 Referent
2 5.4 (5.1–5.6) 271 194 1,069 1.00 0.84, 1.20 0.95 0.79, 1.14 0.95 0.79, 1.14
3 5.8 (5.6–6.1) 292 204 1,088 1.05 0.88, 1.25 1.02 0.85, 1.22 1.02 0.84, 1.23
4 6.5 (6.1–10.0) 286 187 1,080 0.95 0.79, 1.14 0.91 0.76, 1.10 0.91 0.74, 1.12
Trans Fatty Acids
PRESTO
1 1.1 (0.3–1.3) 358 234 1,404 1.00 Referent 1.00 Referent 1.00 Referent
2 1.5 (1.3–1.6) 316 206 1,395 0.91 0.77, 1.08 0.92 0.78, 1.09 0.93 0.78, 1.10
3 1.8 (1.6–2.0) 333 211 1,397 0.94 0.80, 1.12 0.97 0.82, 1.15 0.98 0.82, 1.16
4 2.2 (2.0–4.1) 283 167 1,383 0.78 0.65, 0.93 0.86 0.71, 1.04 0.86 0.71, 1.04
Snart Foraeldre
1 0.4 (0.2–0.5) 270 187 1,062 1.00 Referent 1.00 Referent 1.00 Referent
2 0.5 (0.5–0.6) 304 215 1,122 1.09 0.91, 1.29 1.05 0.88, 1.26 1.06 0.88, 1.27
3 0.6 (0.6–0.7) 275 180 1,054 1.01 0.84, 1.21 0.94 0.78, 1.14 0.96 0.78, 1.17
4 0.8 (0.7–1.9) 277 192 1,069 1.07 0.89, 1.28 1.04 0.86, 1.25 1.06 0.85, 1.32
ω-3 Fatty Acids
PRESTO
1 0.5 (0.3–0.6) 309 182 1,404 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent
2 0.7 (0.6–0.7) 327 213 1,412 1.19 0.99, 1.42 1.21 1.01, 1.46 1.21 1.00, 1.46 1.26 1.02, 1.54
3 0.8 (0.7–1.0) 310 203 1,350 1.12 0.93, 1.34 1.14 0.95, 1.38 1.14 0.93, 1.38 1.19 0.96, 1.46
4 1.3 (1.0–4.4) 344 220 1,413 1.19 0.99, 1.43 1.21 1.01, 1.46 1.20 0.96, 1.49 1.40 1.13, 1.73
Snart Foraeldre
1 0.8 (0.4–0.9) 271 188 1,051 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent
2 1.0 (0.9–1.0) 289 205 1,122 1.00 0.84, 1.19 0.96 0.80, 1.15 0.96 0.80, 1.15 0.98 0.81, 1.20
3 1.1 (1.0–1.2) 284 198 1,080 1.02 0.85, 1.22 0.99 0.82, 1.19 0.99 0.82, 1.20 0.96 0.78, 1.18
4 1.3 (1.2–3.4) 282 183 1,054 0.95 0.79, 1.14 0.92 0.76, 1.11 0.92 0.74, 1.13 0.96 0.78, 1.19
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Table 2. Continued
Study andQuartile % EnergyMedian (Range)
No. of
Women
No. of
Pregnancies
No. of
Cycles at Risk FR
a 95%CI FRb 95%CI FRc 95%CI FRd 95%CI
ω-6 Fatty Acids
PRESTO
1 5.0 (2.1–5.6) 322 199 1,381 1.00 Referent 1.00 Referent 1.00 Referent
2 6.1 (5.6–6.6) 310 201 1,420 1.00 0.84, 1.20 0.97 0.81, 1.16 0.94 0.78, 1.14
3 7.2 (6.6–7.8) 321 208 1,385 1.05 0.88, 1.26 1.04 0.86, 1.24 0.99 0.82, 1.21
4 8.9 (7.8–16.0) 337 210 1,393 1.04 0.87, 1.25 1.03 0.85, 1.23 0.95 0.75, 1.19
Snart Foraeldre
1 3.7 (2.0–3.9) 271 181 1,066 1.00 Referent 1.00 Referent 1.00 Referent
2 4.2 (3.9–4.3) 280 203 1,071 1.09 0.91, 1.30 1.05 0.88, 1.26 1.06 0.88, 1.28
3 4.5 (4.3–4.7) 281 184 1,093 0.96 0.79, 1.15 0.96 0.79, 1.16 0.97 0.80, 1.18
4 5.1 (4.7–8.4) 294 206 1,077 1.08 0.90, 1.29 1.04 0.86, 1.25 1.06 0.86, 1.30
Ratio ofω-3 toω-6 Fatty Acids
PRESTO
1 0.08 (0.04–0.09) 274 161 1,236 1.00 Referent 1.00 Referent 1.00 Referent
2 0.10 (0.10–0.11) 389 254 1,676 1.09 0.91, 1.31 1.13 0.94, 1.36 1.13 0.94, 1.36
3 0.13 (0.12–0.14) 332 221 1,422 1.13 0.94, 1.36 1.17 0.97, 1.41 1.17 0.97, 1.41
4 0.18 (0.15–0.48) 295 182 1,245 1.10 0.90, 1.33 1.09 0.89, 1.33 1.07 0.88, 1.31
Snart Foraeldre
1 0.20 (0.14–0.21) 283 201 1,132 1.00 Referent 1.00 Referent 1.00 Referent
2 0.23 (0.22–0.23) 249 172 938 1.01 0.85, 1.22 0.99 0.82, 1.19 0.99 0.82, 1.19
3 0.25 (0.24–0.26) 293 200 1,086 1.01 0.85, 1.21 0.99 0.83, 1.18 0.99 0.83, 1.19
4 0.29 (0.27–0.70) 301 201 1,151 1.00 0.84, 1.20 1.00 0.84, 1.20 1.01 0.84, 1.21
Abbreviations: CI, conﬁdence interval; FR, fecundability ratio; PRESTO, Pregnancy Study Online.
a Adjusted for total energy intake and age.
b Adjusted for energy intake, age, educational level, body mass index (weight (kg)/height (m)2), smoking status, total physical activity level, parity, alcohol intake, intercourse frequency, mari-
tal status, household income, last method of contraception, and race/ethnicity (PRESTO only).
c Adjusted for the covariates in footnote b and total fat intake.
d Adjusted for the covariates in footnote b and restricted to persons who did not use ω-3 fatty acid supplements (1,025 women (80%) in the PRESTO cohort and 922 women (82%) in the Snart
Foraeldre cohort).
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multivariable models, the highest quartile of SFA intake was
associated with reduced fecundability in PRESTO (for the
fourth quartile vs. the ﬁrst, FR = 0.78, 95% conﬁdence interval
(CI): 0.62, 0.99) but not in SF (for the fourth quartile vs. the
ﬁrst, FR = 0.96, 95%CI: 0.73, 1.27).
TFA intake was associated with reduced fecundability in
PRESTO (for the fourth quartile vs. the ﬁrst, FR = 0.86, 95%CI:
0.71, 1.04) but not in SF (for the fourth quartile vs. the ﬁrst,
FR = 1.04, 95% CI: 0.86, 1.25). Further adjustment for total fat
had little effect on these estimates. Household income had the
largest inﬂuence on the FR (increase in effect estimate = 10%).
In PRESTO, women in the lowest quartile of ω-3 fatty acid
intake had lower fecundability than did women in the other
quartiles, who had similar fecundability (for the fourth quartile
vs. the ﬁrst, FR = 1.21, 95% CI: 1.01, 1.46; for the top 3 quar-
tiles vs. the ﬁrst, FR = 1.19, 95%CI: 1.02, 1.39). There was lit-
tle association between ω-3 fatty acid intake and fecundability
in SF. Further adjustment for total fat intake produced similar
results. Although use of ﬁsh oil supplements was not appreci-
ably associated with fecundability in PRESTO (FR = 1.02,
95% CI: 0.87, 1.19) or SF (FR = 1.03, 95% CI: 0.88, 1.22),
stronger associations between dietary ω-3 intake and fecund-
ability were found among persons who did not take ﬁsh oil
supplements in PRESTO (for the fourth quartile vs. the ﬁrst,
FR = 1.40, 95% CI: 1.13, 1.73; for the top 3 quartiles vs. the
ﬁrst,: FR = 1.27, 95% CI: 1.07, 1.51). Finally, there was little
evidence that intake of ω-6 fatty acids or the ratio of ω-3 to ω-6
fatty acids appreciably inﬂuenced fecundability in either
cohort. In a substitution model in PRESTO in which we re-
placed 1% of energy from ω-3 fatty acids with 1% of energy
from TFA, the FRwas 0.91 (95%CI: 0.78, 1.07).
Restricted cubic spline curves were generally consistent with
results from categorical analyses (Figures 1 and 2). Multivari-
able models in which we adjusted for the remaining fatty acids
yielded results similar to those frommodels adjusted for total fat
and all other covariates (data not shown). Omitting parity from
themodels made little difference in the FRs (data not shown).
When we stratiﬁed the data by attempt time at study entry,
the associations of fecundability with TFA and ω-3 fatty acids
were somewhat stronger among PRESTO participants with
shorter attempt times, indicating little evidence of bias due to
reverse causation (Table 3). Age stratiﬁcation also produced
relatively uniform ﬁndings (Table 4). In PRESTO, the inverse
association between TFA intake and fecundability was stron-
ger among lean women (Table 5). In contrast to the overall re-
sults, FRs increased monotonically with increasing intake of
ω-3 fatty acids among lean women, but little association was
observed among overweight women. In SF, ﬁndings were gen-
erally similar across overweight strata with the exception of ω-
6 fatty acids, for which high intake was associated with
increased fecundability among lean women but reduced fe-
cundability among overweight/obese women.
DISCUSSION
In the present study, there was little evidence of an association
between fecundability and intakes of total fat, SFAs, MUFAs,
PUFAs, or ω-6 fatty acids. However, there was some suggestion
that high TFA intake and low ω-3 fatty acid intake were associ-
ated with reduced fecundability among North American women.
These associations were slightly stronger among leanwomen and
womenwith shorter attempt times at study entry, but they did not
vary materially by age or with further adjustment for total fat
intake. Controlling for socioeconomic status, particularly house-
hold income, attenuated these associations. There was little asso-
ciation between use of ﬁsh oil supplements and fecundability.
Our ﬁndings for TFA intake are consistent with those from the
Nurses’ Health Study II (5), a prospective cohort study in which
TFA intake was associated with an increased risk of ovulatory
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Figure 1. Association between percentage of energy from trans fatty acids and fecundability, ﬁtted by restricted cubic splines, Pregnancy Study
Online (A), United States and Canada, and Snart Foraeldre (B), Denmark, 2013–2016. A) The reference level is 0.91 (5th percentile of the distribution).
There are 3 knots located at 10th, 50th, and 90th percentiles (1.04, 1.57, and 2.25). The solid line indicates the fecundability ratio, and the dashed lines
indicate the 95% conﬁdence bounds. B) The reference level is 0.35 (5th percentile of the distribution). There are 3 knots located at 10th, 50th, and 90th
percentiles (0.39, 0.57, and 0.84). The solid line indicates the fecundability ratio, and the dashed lines indicate the 95%conﬁdence bounds.
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infertility during a 9-year period (1991–1999) (5). Because we
examined all types of subfertility, not just ovulatory infertility, as-
sociations may have been attenuated or obscured if intakes of
speciﬁc subtypes of fat have an effect on ovarian function but not
on other types of subfertility (e.g., tubal blockage). TFAs were
eliminated from the Danish food supply in 2003 (39), and their
low prevalence could explain the lack of association between
TFA intake and fecundability in SF. Although food labeling for
TFA is required in North America and restaurant use has been
reduced, TFAs have not been banned.
Ourﬁndings forω-3 fatty acids agreewith those from a cohort
of 259 regularly menstruating women in the BioCycle Study, in
which dietary intake of docosapentaenoic acid—a fatty acid
commonly found in ﬁsh—was associated with a lower risk of
anovulation. In addition, higher dietary intake of total marine
ω-3 polyunsaturated fats—speciﬁcally eicosapentaenoic acid, doc-
osahexaenoic acid, and docosapentaenoic acid—was associated
with increased luteal-phase progesterone concentrations (13).
To our knowledge, there are no other studies of ω-3 fatty acids
and reproductive-related endpoints in women. Our results for
ω-6 fatty acids conﬂict with those froma study of infertilewomen,
in which higher preconception intakes ofω-6 fatty acid and lino-
leic acid (PUFA) were associated with a higher probability of
pregnancy among 46 overweight/obese women who were
undergoing in vitro fertilization (14). Finally, the lack of associa-
tion between ﬁsh oil supplements and fecundability is difﬁcult
to explain. Supplements can vary widely in their quality and
content (40), which would lead to misclassiﬁcation, and indivi-
duals who take supplements might have vastly different diets or
family histories of illnesses (e.g., heart disease), which could
have produced unmeasured confounding. Finally, if supple-
ments contain more contaminants (e.g., mercury in ﬁsh) than
ﬁsh themselves, any beneﬁcial effects on fertility could be
negated.
Strengths of the present study include enrollment during the
preconception period, with more than two-thirds of women
enrolled during theirﬁrst 3 cycles of attempted pregnancy. Die-
tary assessment before pregnancy avoids recall bias. Cohort
retention exceeded 80% in both cohorts during the follow-up
period. The median length of follow-up was identical (9 cy-
cles) for those in the highest and lowest quartiles of total fat
intake. Data were collected on a wide range of potential con-
founders. FFQs were validated in each population, showing
high relative validity of nutrients of interest.
Although the FFQ is the most feasible method for assessing
long-term diet in large epidemiologic studies (34, 41, 42), some
misclassiﬁcation of diet is expected. It should also be noted that
country-speciﬁc dietary databases were used in the 2 studies.
Estimation of macronutrients, including fatty acids, are based on
laboratory analysis with extrapolation to similar foods; thus, we
do not expect such differences to have materially affected the re-
sults. Because diet was assessed prospectively relative to the out-
come, any misclassiﬁcation in our studies was likely to be
nondifferential and would attenuate extreme categories of fat
intake towards the null. Residual confounding is another possi-
ble explanation of our ﬁndings. Consumption of TFA—which
is typically found in highly processed foods—is associated with
unhealthful lifestyle practices. Thus, confounding by unmea-
sured covariates associated with unhealthful lifestyle factors that
were not captured by measured variables such as sedentariness,
adiposity, and energy intake may have biased our results.
Another limitation is that we did not control for the male part-
ners’ dietary intakes, which may be correlated with female part-
ners’ intakes. Epidemiologic studies have shown associations
between poor semen quality and both high intake of TFA (43,
44) and docosahexaenoic acid deﬁciency (10–12). Finally, there
could be nondietary factors that explain the inconsistent results
across cohorts. For example, factors by which Danes differ from
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Figure 2. Association between percentage of energy from ω-3 fats and fecundability among those who did not consume ﬁsh oil supplements, ﬁt-
ted by restricted cubic splines, Pregnancy Study Online (A), United States and Canada, and Snart Foraeldre (B), Denmark, 2013–2016. A) The ref-
erence level is 0.43. There are 3 knots located at 10th, 50th, and 90th percentiles (0.49, 0.72, and 1.36). The solid line indicates the fecundability
ratio, and the dashed lines indicate the 95% conﬁdence bounds. After restriction to those who did not consume ﬁsh oil supplements, n = 1,025. B)
The reference level is 0.43. There are 3 knots located at 10th, 50th, and 90th percentiles (0.81, 1.04, and 1.36). The solid line indicates the fecund-
ability ratio, and the dashed lines indicate 95% conﬁdence bounds. After restriction to those who did not consume ﬁsh oil supplements, n = 730.
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NorthAmericans (e.g., lower stress and pollution levels, reduced
socioeconomic inequality) could interact with dietary fat intake
and produce different associations with fecundity.
FFQ estimates for fat intake in our cohorts were consistent
with national data on reproductive-aged women (45–47). These
observations, coupled with the ﬁnding that our results did not
vary materially by other covariates, suggest that our results are
generalizable to other reproductive-aged women. Web-based
recruitment has been criticized because of differences in the
characteristics of persons with and without Internet access (48).
However, this recruitment method would not affect the validity
of the study results unless the relationship between diet and fer-
tility differed substantially between those who did and did not
use the Internet, which is unlikely (49). The same argument can
Table 3. Association Between Dietary Fat Intake and Fecundability, Stratiﬁed by Pregnancy Attempt Time at Study Entry, Pregnancy Study
Online (n= 1,290), United States and Canada, and Snart Foraeldre (n= 1,126), Denmark, 2013–2016
Study and
Quartile Median (Range)
Attempt Time at Study Entry
<3 Cycles 3–6 Cycles
No. of
Pregnancies
No. of
Cycles at Risk FR
a 95%CI No. ofPregnancies
No. of
Cycles at Risk FR
a 95%CI
%Energy From Trans Fatty Acids
PRESTO
1 1.1 (0.3–1.3) 171 933 1.00 Referent 63 471 1.00 Referent
2 1.5 (1.3–1.6) 155 950 0.97 0.80, 1.19 51 445 0.97 0.77, 1.23
3 1.8 (1.6–2.0) 162 991 1.02 0.84, 1.25 49 406 0.94 0.75, 1.16
4 2.2 (2.0–4.1) 114 973 0.80 0.63, 1.00 53 410 0.98 0.83, 1.16
Snart Foraeldre
1 0.4 (0.2–0.5) 145 786 1.00 Referent 42 276 1.00 Referent
2 0.5 (0.5–0.6) 157 795 1.05 0.86, 1.29 58 327 1.05 0.89, 1.25
3 0.6 (0.6–0.7) 128 748 0.91 0.73, 1.13 52 306 1.01 0.86, 1.20
4 0.8 (0.7–1.9) 141 757 1.02 0.83, 1.26 51 312 1.04 0.87, 1.24
%Energy Fromω-3 Fatty Acids
PRESTOb
1 0.5 (0.3–0.6) 105 873 1.00 Referent 49 359 1.00 Referent
2 0.7 (0.6–0.7) 127 777 1.43 1.12, 1.82 45 400 0.90 0.76, 1.08
3 0.8 (0.7–1.0) 118 736 1.37 1.07, 1.75 35 310 0.90 0.68, 1.19
4 1.3 (1.0–4.4) 117 647 1.52 1.18, 1.96 45 314 0.96 0.80, 1.15
Snart Foraeldreb
1 0.8 (0.4–0.9) 115 637 1.00 Referent 41 252 1.00 Referent
2 1.0 (0.9–1.0) 121 664 0.94 0.75, 1.19 45 254 1.08 0.86, 1.35
3 1.1 (1.0–1.2) 115 640 0.97 0.76, 1.23 45 284 1.02 0.83, 1.25
4 1.3 (1.2–3.4) 106 541 0.97 0.76, 1.23 42 261 0.97 0.80, 1.19
%Energy From Total Fat
PRESTO
1 30.2 (15.5–32.9) 138 943 1.00 Referent 54 452 1.00 Referent
2 34.9 (32.9–37.0) 144 931 1.12 0.90, 1.39 62 459 0.99 0.75, 1.31
3 39.4 (37.0–42.0) 161 940 1.18 0.95, 1.45 55 462 0.92 0.68, 1.23
4 45.4 (42.1–67.2) 159 1,033 1.11 0.90, 1.38 45 359 0.98 0.72, 1.32
Snart Foraeldre
1 30.4 (15.1–32.7) 145 778 1.00 Referent 51 300 1.00 Referent
2 34.4 (32.7–35.7) 138 773 0.95 0.77, 1.17 45 298 0.93 0.72, 1.19
3 37.5 (35.7–39.4) 148 730 1.06 0.86, 1.30 66 351 1.03 0.88, 1.21
4 41.8 (39.4–66.4) 140 805 0.92 0.74, 1.14 41 272 0.98 0.77, 1.25
Abbreviations: CI, conﬁdence interval; FR, fecundability ratio; PRESTO, Pregnancy StudyOnline.
a Adjusted for energy intake, age, body mass index (weight (kg)/height (m)2), smoking status, total physical activity level, educational level, parity,
alcohol intake, intercourse frequency, marital status, household income, last method of contraception, and race/ethnicity (PRESTOonly).
b Restricted to persons who did not use ﬁsh oil supplements.
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be made regarding differences between womenwho did and did
not plan pregnancy. Our study (50) and others (51, 52) have
shown that even when participation at cohort entry is related to
characteristics such as age, parity, or smoking, measures of asso-
ciation are not biased because of self-selection. Concerns about
selection bias stemming from length-biased recruitment of cou-
ples with longer TTP or misclassiﬁcation arising from changes
in diet over time because of subfertility can be assessed by strati-
fying by attempt time at study entry. Selected results were slightly
stronger among women with shorter attempt times at study entry,
providing little support for selection bias.
Our ﬁndings are biologically plausible. TFA intake has been
associated with inﬂammation (53) and insulin resistance (54),
both ofwhich are known to impair ovulatory function. In addition
Table 4. Association Between Dietary Fat Intake and Fecundability, Stratiﬁed by Age at Baseline, Pregnancy Study Online (n= 1,290), United
States and Canada, and Snart Foraeldre (n= 1,126), Denmark, 2013–2016
Study and
Quartile Median (Range)
Age at Baseline, years
<30 ≥30
No. of
Pregnancies
No. of
Cycles at Risk FR
a 95%CI No. ofPregnancies
No. of
Cycles at Risk FR
a 95%CI
%Energy From Trans Fatty Acids
PRESTO
1 1.1 (0.3–1.3) 101 550 1.00 Referent 133 854 1.00 Referent
2 1.5 (1.3–1.6) 92 607 0.94 0.73, 1.22 114 788 0.99 0.79, 1.25
3 1.8 (1.6–2.0) 109 693 1.00 0.78, 1.29 102 704 0.98 0.78, 1.25
4 2.2 (2.0–4.1) 95 730 0.90 0.69, 1.18 72 653 0.82 0.62, 1.07
Snart Foraeldre
1 0.4 (0.2–0.5) 121 698 1.00 Referent 66 364 1.00 Referent
2 0.5 (0.5–0.6) 136 662 1.09 0.87, 1.36 79 460 1.04 0.77, 1.41
3 0.6 (0.6–0.7) 122 719 0.91 0.73, 1.15 58 335 1.13 0.81, 1.56
4 0.8 (0.7–1.9) 124 722 0.92 0.73, 1.16 68 347 1.27 0.93, 1.73
%Energy Fromω-3 Fatty Acids
PRESTOb
1 0.5 (0.3–0.6) 91 657 1.00 Referent 63 575 1.00 Referent
2 0.7 (0.6–0.7) 90 629 1.13 0.86, 1.50 82 548 1.37 1.01, 1.86
3 0.8 (0.7–1.0) 75 499 1.06 0.80, 1.41 78 547 1.25 0.91, 1.71
4 1.3 (1.0–4.4) 70 365 1.32 0.98, 1.77 92 596 1.34 0.98, 1.82
Snart Foraeldreb
1 0.8 (0.4–0.9) 103 562 1.00 Referent 53 327 1.00 Referent
2 1.0 (0.9–1.0) 103 607 0.91 0.71, 1.16 63 311 1.21 0.86, 1.71
3 1.1 (1.0–1.2) 112 620 0.96 0.75, 1.23 48 304 1.02 0.69, 1.50
4 1.3 (1.2–3.4) 91 516 0.87 0.67, 1.12 57 286 1.15 0.79, 1.66
%Energy From Total Fat
PRESTO
1 30.2 (15.5–32.9) 98 704 1.00 Referent 94 691 1.00 Referent
2 34.9 (32.9–37.0) 103 710 1.07 0.83, 1.39 103 680 1.16 0.90, 1.50
3 39.4 (37.0–42.0) 105 609 1.14 0.88, 1.47 111 793 1.06 0.83, 1.36
4 45.4 (42.1–67.2) 91 557 1.07 0.82, 1.39 113 835 1.12 0.86, 1.45
Snart Foraeldre
1 30.4 (15.1–32.7) 127 695 1.00 Referent 69 383 1.00 Referent
2 34.4 (32.7–35.7) 111 642 0.85 0.68, 1.07 72 429 1.00 0.73, 1.36
3 37.5 (35.7–39.4) 132 704 0.96 0.77, 1.20 82 377 1.21 0.91, 1.61
4 41.8 (39.4–66.4) 133 760 0.87 0.70, 1.08 48 317 0.90 0.64, 1.27
Abbreviations: CI, conﬁdence interval; FR, fecundability ratio; PRESTO, Pregnancy StudyOnline.
a Adjusted for energy intake, age, body mass index (weight (kg)/height (m)2), smoking status, total physical activity level, educational level, parity,
alcohol intake, intercourse frequency, marital status, household income, last method of contraception, and race/ethnicity (PRESTOonly).
b Restricted to persons who did not use ﬁsh oil supplements.
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Table 5. Association Between Dietary Fat Intake and Fecundability, Stratiﬁed by BodyMass Index, Pregnancy Study Online (n= 1,290), United
States and Canada, and Snart Foraeldre (n= 1,126), Denmark, 2013–2016
Study and
Quartile
Median
(Range)
BodyMass Indexa
<25 ≥25
No. of
Pregnancies
No. of
Cycles at Risk FR
b 95%CI No. ofPregnancies
No. of
Cycles at Risk FR
b 95%CI
%Energy From Trans Fatty Acids
PRESTO
1 1.1 (0.3–1.3) 159 828 1.00 Referent 75 576 1.00 Referent
2 1.5 (1.3–1.6) 115 766 0.79 0.64, 0.99 91 629 1.05 0.92, 1.19
3 1.8 (1.6–2.0) 127 790 0.86 0.69, 1.06 84 607 1.05 0.90, 1.21
4 2.2 (2.0–4.1) 84 547 0.80 0.69, 1.03 83 836 0.97 0.82, 1.15
Snart Foraeldre
1 0.4 (0.2–0.5) 131 773 1.00 Referent 56 289 1.00 Referent
2 0.5 (0.5–0.6) 153 801 1.11 0.90, 1.37 62 321 0.95 0.69, 1.31
3 0.6 (0.6–0.7) 132 728 1.02 0.82, 1.27 48 326 0.75 0.53, 1.07
4 0.8 (0.7–1.9) 123 725 1.07 0.86, 1.34 69 344 1.21 0.64, 2.31
%Energy Fromω-3 Fatty Acids
PRESTOc
1 0.5 (0.3–0.6) 87 593 1.00 Referent 67 639 1.00 Referent
2 0.7 (0.6–0.7) 86 543 1.13 0.85, 1.49 86 634 1.11 0.86, 1.43
3 0.8 (0.7–1.0) 88 535 1.18 0.90, 1.56 65 511 1.06 0.86, 1.30
4 1.3 (1.0–4.4) 112 576 1.41 1.09, 1.83 50 385 1.03 0.83, 1.28
Snart Foraeldrec
1 0.8 (0.4–0.9) 109 633 1.00 Referent 47 256 1.00 Referent
2 1.0 (0.9–1.0) 117 654 0.98 0.77, 1.25 49 264 1.02 0.71, 1.46
3 1.1 (1.0–1.2) 113 653 1.00 0.79, 1.28 47 271 0.84 0.56, 1.25
4 1.3 (1.2–3.4) 100 539 1.00 0.78, 1.28 48 263 0.93 0.62, 1.39
%Energy Fromω-6 Fatty Acids
PRESTO
1 5.0 (2.1–5.6) 111 704 1.00 Referent 88 677 1.00 Referent
2 6.1 (5.6–6.6) 116 738 0.95 0.75, 1.20 85 682 0.98 0.86, 1.11
3 7.2 (6.6–7.8) 123 682 1.10 0.87, 1.39 85 703 0.98 0.86, 1.11
4 8.9 (7.8–16.0) 135 807 1.03 0.81, 1.30 75 586 0.99 0.86, 1.13
Snart Foraeldre
1 3.7 (2.0–3.9) 124 776 1.00 Referent 57 290 1.00 Referent
2 4.2 (3.9–4.3) 141 772 1.10 0.89, 1.37 62 299 0.94 0.68, 1.31
3 4.5 (4.3–4.7) 137 813 1.04 0.84, 1.30 47 280 0.81 0.57, 1.15
4 5.1 (4.7–8.4) 137 666 1.26 1.01, 1.57 69 411 0.73 0.53, 1.02
Ratio ofω-3 toω-6 Fatty Acids
PRESTO
1 0.1 (0.0–0.1) 94 660 1.00 Referent 67 576 1.00 Referent
2 0.1 (0.1–0.1) 150 827 1.26 1.00, 1.60 104 849 0.99 0.86, 1.14
3 0.1 (0.1–0.1) 125 715 1.25 0.98, 1.60 96 707 1.00 0.88, 1.14
4 0.2 (0.2–0.5) 116 729 1.19 0.93, 1.53 66 516 0.97 0.78, 1.20
Snart Foraeldre
1 0.2 (0.1–0.2) 142 765 1.00 Referent 59 367 1.00 Referent
2 0.2 (0.2–0.2) 116 646 0.95 0.76, 1.18 56 292 1.12 0.79, 1.58
3 0.3 (0.2–0.3) 134 785 0.93 0.75, 1.15 66 301 1.33 0.94, 1.87
4 0.3 (0.3–0.7) 147 831 0.97 0.79, 1.19 54 320 1.08 0.76, 1.55
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to their own anti-inﬂammatory effects (55), ω-3 fatty acids may
improve fecundity by reducing the likelihood of anovulation
(13), supporting optimal endogenous progesterone levels (13),
and increasing the prostacyclin/thromboxane ratio (56), thereby
increasing uterine blood ﬂow (57).
In summary, 2 prospective cohort studies of women from
North America and Denmark who were attempting to become
pregnant showed little evidence of an association between fe-
cundability and intakes of total dietary fat, SFA,MUFA, PUFA,
and ω-6 fatty acids. High intake of TFAs and low intake of ω-3
fatty acids were associated with reduced fecundability among
North Americans only. The low prevalence of TFA intake in
Denmark limited our ability to assess its association with fe-
cundability in this population. The higher median intake of
ω-3 fatty acids in Denmark and its lack of association with fe-
cundability is consistent with our ﬁnding of a threshold effect
affecting the lowest quartile of intake in the North American
cohort. Our ﬁndings agree with those from the small number of
previous studies of this topic, but further research is warranted to
conﬁrm our results.
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